Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database.

Hussein, Mohamed; Wei, Wenhui; Mastey, Vera; Sanchez, Robert J; Wang, Degang; Murdock, Dana J; Hirshberg, Boaz; Weinreich, David M; Jalbert, Jessica J

Hussein, Mohamed; Wei, Wenhui; Mastey, Vera; Sanchez, Robert J; Wang, Degang; Murdock, Dana J; Hirshberg, Boaz; Weinreich, David M; Jalbert, Jessica J.

Afiliación

Hussein M; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA mohamed.hussein@regeneron.com.
Wei W; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.
Mastey V; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.
Sanchez RJ; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.
Wang D; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.
Murdock DJ; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.
Hirshberg B; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.
Weinreich DM; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.
Jalbert JJ; Regeneron Pharmaceuticals Inc, Tarrytown, New York, USA.

BMJ Open ; 12(12): e064953, 2022 12 19.

Article en En | MEDLINE | ID: mdl-36535724

Asunto(s)

COVID-19; Humanos; Femenino; Masculino; Vacunas contra la COVID-19; Estudios Retrospectivos; Anticuerpos Neutralizantes

Palabras clave

COVID-19; INFECTIOUS DISEASES; PUBLIC HEALTH; RESPIRATORY MEDICINE (see Thoracic Medicine); VIROLOGY

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: BMJ Open Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google